Wholesalers hold supplies of cannabis-based drugs after import change
Pharmacy wholesalers are able to hold supplies of cannabis-based medicines for future use by patients who have prescriptions for those drugs under new measures that have been introduced by the Government.
The Department of Health and Social Care (DHSC) said a change to import restrictions, which came into affect on Monday, will give patients access to treatments within days rather than months.
Under the new measures, wholesalers can import larger amounts of cannabis-based products and hold supplies for future use.
“Most cannabis-based medicines are imported from foreign countries. Export restrictions mean it can take weeks or months for the drugs to reach the patients in the UK,” the DHSC said.
“For example, in Canada, an export certificate can take four to eight weeks.
“In addition, safeguards against addiction and the misuse of drugs mean that patients with prescriptions for unlicensed medicines, such as medicinal cannabis, need to have their prescription reviewed every 30 days by specialist doctors.
“This can lead to delays in treatment if there are also delays to imports.”
A change in legislation in October 2018 allowed specialist doctors to prescribe cannabis-based products for medicinal use where it is clinically appropriate.
Two cannabis-based medicines were recommended last year by the National Institute for Health and Care Excellence for the treatment of multiple sclerosis and certain epilepsies.
“Every time I meet the families of young people dealing so bravely with childhood epilepsy, I am reminded of just how much they have been through,” said Health secretary Matt Hancock (pictured).
“(These) changes made are a tremendous step towards improving the supply of cannabis-based medicinal products by helping to ensure quicker and more reliable access for patients.
“But we still have a long way to go. We need more research into the quality and safety of these medicines, and to do all we can to cut down the costs and remove barriers so that, when appropriate, patients can access it, including on the NHS.”
Record my learning outcomes
Inspiring stories related to health, fitness and the pursuit of wellbeing
More like this
Covid cost claims 'significantly higher' than Government's offer
PSNC has not revealed total claims amount but says it is well above original £120m offer.
1 Min Article
Half of community pharmacists consider switch to general practice
Community pharmacy could be facing a workforce crisis, an exclusive survey finds.
2 Min Article
EPB chair: Don't take away pharmacists' Covid vaccine indemnity
Govind warns minister that removing indemnity will hinder jabs delivery.
1 Min Article
Treating acid reflux and heartburn in the pharmacy
Understand how omeprazole 20mg works to treat heartburn and acid reflux symptoms
2 Min Module
Managing hay fever: help meet your customers' needs
This module will improve your hay fever knowledge, helping you to understand its impact on sufferers and recommend the right products to ease symptoms
15 Min Module
Covid-19 and mental health
Viatris has created this short video based on a publication reviewing global research into the potential impact of the Covid-19 pandemic on mental health. It identifies six areas where psychiatrists can play a role in supporting people's mental health through these difficult times.
4 Min Module